Protecting Human Rights in a Global Economy Challenges for the World Trade Organization

2001 ◽  
pp. 51-82
1996 ◽  
Vol 45 (3) ◽  
pp. 592-632 ◽  
Author(s):  
Halina Ward

In June 1992 the UN Conference on Environment and Development (UNCED) took place in Rio de Janeiro; 1993 was the year of the World Conference on Human Rights, 1994 the year of the Cairo International Conference on Population and Development, and in March 1995 it was the turn of the World Summit for Social Development in Copenhagen.


2009 ◽  
Author(s):  
Sarah Joseph ◽  
David Kinley ◽  
Jeff Waincymer

2003 ◽  
Vol 25 (2) ◽  
Author(s):  
Peter Binger

AbstractThe following response to the essays by Dietrich, Kesselring and Schefczyk discusses impartiality and foundations of special duties; utilitarianism, foreign aid, NGOs and human rights; and ethical aspects of free trade and the World Trade Organization.


Author(s):  
Janice M. Mueller

The first day of January 2005 marked a dramatic turning point in the history of India. By deliberately excluding pharmaceutical products from patent protection for the previous 34 years, India became a world leader in high-quality generic drug manufacturing. But India’s entry into the global economy at the end of the 20th century, as evidenced by membership in the World Trade Organization (WTO), compelled the nation to once again award patents on drugs. Moreover, India henceforth would have to apply internationally-accepted criteria for granting patents, and the term of its patents would have to extend twenty years beyond filing.


Author(s):  
Suerie Moon ◽  
Thirukumaran Balasubramaniam

The ability of governments to protect and promote health-related human rights can be constrained by international trade rules, including those of the World Trade Organization (WTO). The WTO rules can increase medicine prices, challenge tobacco control measures, restrict national food safety policies, and facilitate brain drain from public health services. This chapter offers a brief history of the WTO’s origins, a high-level overview of the health implications of various WTO agreements, and a closer look at how two key issues—access to medicines and tobacco control—have created greater policy space for health within the WTO. It then identifies the institutional factors that promote or hinder human rights protection and offers conclusions on the prospects for institutionalization of health-related human rights. This chapter concludes that protecting health within the WTO and broader global trade regime is possible, but remains a significant challenge due to major power asymmetries.


Sign in / Sign up

Export Citation Format

Share Document